StonvexLoading…
StonvexStonvexStonvexCore line items from ZTO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.02B | $6.07B | $5.41B | $5.13B |
Operating Income | $1.50B | $1.61B | $1.41B | $1.12B |
Net Income | $1.30B | $1.21B | $1.23B | $987.22M |
EPS (Diluted) | $1.60 | $1.47 | $1.49 | $1.21 |
Total Assets | $13.02B | $12.65B | $12.46B | $11.38B |
Total Liabilities | $3.42B | $4.06B | $3.97B | $3.49B |
Cash & Equivalents | $1.43B | $1.84B | $1.74B | $1.70B |
Free Cash Flow OCF − CapEx | $965.83M | $852.31M | $962.28M | $639.62M |
Shares Outstanding | 790.81M | 798.62M | 804.72M | 809.25M |